Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756977 · ClinicalTrials.gov registry record · Phase 3
BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
A Phase 3 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 394
- Enrollment target
NCT00756977 is a Phase 3 study that has completed, run by Braintree Laboratories. The registered enrollment target is 394 participants.
The verdict
NCT00756977, a Phase 3 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 394 participants
- Enrollment target
Study Summary
This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
Interventions
- DRUG BLI850
- DRUG polyethylene glycol 3350 based bowel preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00756977
The ClinicalTrials.gov registry entry for NCT00756977 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 394 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI850 is the first listed.
NCT00756977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00756977 about?
NCT00756977 is a clinical study titled "BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy". This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.
What is the current status of trial NCT00756977?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 394 participants. The study started on 2008-08.
What interventions are being tested in trial NCT00756977?
The interventions under investigation include: BLI850 (DRUG), polyethylene glycol 3350 based bowel preparation (DRUG).
Who is sponsoring clinical trial NCT00756977?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.